Vincera Pharma, Inc. (VINC) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 35 transactions totaling $1.1M, demonstrating a bullish sentiment with $1.1M in net insider flow. The most recent transaction on Aug 11, 2023 involved a purchase of 10,500 shares valued at $10.0K.
No significant insider buying has been recorded for VINC in the recent period.
No significant insider selling has been recorded for VINC in the recent period.
Based on recent SEC filings, insider sentiment for VINC is bullish with an Insider Alignment Score of 100/100 and a net flow of $1.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Vincera Pharma, Inc. (VINC) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading VINC stock, having executed 35 transactions in the past 90 days. The most active insider is Ahmed Hamdy Md (Executive), who has made 7 transactions totaling $250.7K.
Get notified when executives and directors at VINC file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Aug 11, 2023 | A. Seelenberger Alexander | Executive | Purchase | 10,500 | $0.95 | $10.0K | |
| Aug 10, 2023 | E. Izumi Raquel | Executive | Purchase | 3,440 | $0.93 | $3.2K | |
| Aug 10, 2023 | C. Thomas Tom | Executive | Purchase | 5,000 | $0.95 | $4.8K | |
| Aug 10, 2023 | Hamdy Ahmed Md | Executive | Purchase | 5,400 | $0.96 | $5.2K | |
| Aug 9, 2023 | E. Izumi Raquel | Executive | Purchase | 13,036 | $0.90 | $11.7K | |
| Aug 9, 2023 | Hamdy Ahmed Md | Executive | Purchase | 16,900 | $0.95 | $16.1K | |
| Dec 14, 2022 | C. Thomas Tom | Executive | Purchase | 7,000 | $0.83 | $5.8K | |
| Dec 14, 2022 | Hamdy Ahmed Md | Executive | Purchase | 35,280 | $0.87 | $30.7K | |
| Dec 14, 2022 | E. Izumi Raquel | Executive | Purchase | 28,738 | $0.88 | $25.3K | |
| Aug 25, 2022 | P. Lowe Christopher | Executive | Purchase | 11,600 | $1.65 | $19.1K | |
| Aug 24, 2022 | P. Lowe Christopher | Executive | Purchase | 18,400 | $1.65 | $30.4K | |
| Jun 27, 2022 | E. Izumi Raquel | Executive | Purchase | 40,000 | $1.41 | $56.4K | |
| Jun 23, 2022 | Hamdy Ahmed Md | Executive | Purchase | 24,200 | $1.41 | $34.1K | |
| Jun 9, 2022 | I. Bushnell Laura | Executive | Purchase | 15,000 | $1.91 | $28.6K | |
| Dec 23, 2021 | Hwang Sooin | Executive | Purchase | 3,000 | $10.00 | $30.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 29 | $1.1M | 100.0% |
Other(J) | 2 | $0 | 0.0% |
Award(A) | 4 | $0 | 0.0% |
Insiders at Vincera Pharma, Inc. are accumulating shares at an accelerated pace. With 11 insiders making 35 transactions totaling $1.1M in purchases versus $0 in sales, the net buying activity of $1.1M signals strong executive confidence. Ahmed Hamdy Md (Executive) leads the buying activity with $250.7K in transactions across all time.